XBIOW
Xenetic Biosciences, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
James F. Parslow
IPO Date
2019-07-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Xenetic Biosciences, Inc.
CEO
James F. Parslow
IPO Date
2019-07-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 20,000 |
| $3.88 |
| 13 Dec 2023 | PARSLOW JAMES F | Chief Financial Officer | A-Award | Acquired | 10,000 | $3.88 |
| 8 Dec 2023 | Dastoor Firdaus J. | director | A-Award | Acquired | 2,500 | $4.29 |
| 8 Dec 2023 | Kornberg Roger D. | director | A-Award | Acquired | 2,500 | $4.29 |
| 8 Dec 2023 | Callaway James Eric | director | A-Award | Acquired | 2,500 | $4.29 |
| 8 Dec 2023 | VINOGRADOV ALEXEY ANDREEVICH | director | A-Award | Acquired | 2,500 | $4.29 |
| 8 Dec 2023 | Borisenko Grigory G. | director | A-Award | Acquired | 2,500 | $4.29 |
| 8 Dec 2023 | Logal Adam | director | A-Award | Acquired | 2,500 | $4.29 |
| 9 Dec 2022 | Dastoor Firdaus J. | director | A-Award | Acquired | 25,000 | $0.00 |